Among these seven genes, prostate-specific membrane antigen (PSMA) and alpha-methylacyl-CoA racemase (AMACR) are well-known diagnostic and, in the case of PSMA, prognostic markers of prostate cancer progression40, 41, 42, 43, 44. This evidence concerns the gene FOLH1 and Familial prostate cancer.